Pages that link to "Q34154777"
Jump to navigation
Jump to search
The following pages link to Anandamide and noladin ether prevent neurotoxicity of the human amyloid-beta peptide. (Q34154777):
Displaying 41 items.
- The endocannabinoid system as an emerging target of pharmacotherapy (Q24648473) (← links)
- A molecular link between the active component of marijuana and Alzheimer's disease pathology (Q24657485) (← links)
- Alzheimer's disease; taking the edge off with cannabinoids? (Q24681412) (← links)
- Harm reduction--the cannabis paradox (Q24814542) (← links)
- Potential Therapeutical Contributions of the Endocannabinoid System towards Aging and Alzheimer's Disease (Q26783325) (← links)
- Endocannabinoid system: emerging role from neurodevelopment to neurodegeneration (Q30391852) (← links)
- Neuropharmacology of the endocannabinoid signaling system-molecular mechanisms, biological actions and synaptic plasticity. (Q30493991) (← links)
- The Role of Neurotransmitters in Protection against Amyloid- β Toxicity by KiSS-1 Overexpression in SH-SY5Y Neurons (Q33711261) (← links)
- Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: a neuroprotective therapeutic modality (Q34018061) (← links)
- Endocannabinoids Prevent β-Amyloid-mediated Lysosomal Destabilization in Cultured Neurons (Q34352311) (← links)
- Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation. (Q34397288) (← links)
- Sulfonyl fluoride inhibitors of fatty acid amide hydrolase (Q34452685) (← links)
- Intrinsic up-regulation of 2-AG favors an area specific neuronal survival in different in vitro models of neuronal damage (Q34531690) (← links)
- Acute and non-acute effects of cannabis on brain functioning and neuropsychological performance (Q34581675) (← links)
- Endocannabinoid 2-arachidonoylglycerol protects neurons against β-amyloid insults (Q34642593) (← links)
- The endocannabinoid system and Alzheimer's disease (Q34704881) (← links)
- WIN 55,212-2, agonist of cannabinoid receptors, prevents amyloid β1-42 effects on astrocytes in primary culture. (Q35601542) (← links)
- Immunolocalization of Kisspeptin Associated with Amyloid-β Deposits in the Pons of an Alzheimer's Disease Patient (Q35623440) (← links)
- Role of hydrogen peroxide in the aetiology of Alzheimer's disease: implications for treatment. (Q35666080) (← links)
- Cannabinoids and Dementia: A Review of Clinical and Preclinical Data (Q36155898) (← links)
- Kisspeptin prevention of amyloid-β peptide neurotoxicity in vitro (Q36248549) (← links)
- N-Stearoyl-L-Tyrosine Inhibits the Senescence of Neural Stem/Progenitor Cells Induced by Aβ 1-42 via the CB2 Receptor (Q36637614) (← links)
- Cyclooxygenase-2 in synaptic signaling (Q36922736) (← links)
- The therapeutic potential of the endocannabinoid system for Alzheimer's disease (Q37997020) (← links)
- Cannabinoids for treatment of Alzheimer's disease: moving toward the clinic. (Q38196398) (← links)
- Cannabinoids in late-onset Alzheimer's disease (Q38383508) (← links)
- New approaches in the design and development of cannabinoid receptor ligands: multifunctional and bivalent compounds (Q38395251) (← links)
- Cannabinoid effects on β amyloid fibril and aggregate formation, neuronal and microglial-activated neurotoxicity in vitro. (Q39096624) (← links)
- Endocannabinoid system in neurodegenerative disorders. (Q39368845) (← links)
- Characterization of NTera2/D1 cells as a model system for the investigation of cannabinoid function in human neurons and astrocytes (Q39524238) (← links)
- Anandamide protects from low serum-induced apoptosis via its degradation to ethanolamine (Q40182562) (← links)
- Cannabinoid CB1 receptor activation does not prevent the toxicity of glutamate towards embryonic chick telencephalon primary cultures (Q44682493) (← links)
- Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells (Q44804966) (← links)
- CB1 and TRPV1 receptors mediate protective effects on colonic electrophysiological properties in mice (Q46963575) (← links)
- Cannabinoid Receptor Type 1 Agonist ACEA Protects Neurons from Death and Attenuates Endoplasmic Reticulum Stress-Related Apoptotic Pathway Signaling (Q47406095) (← links)
- COX-2 oxidative metabolite of endocannabinoid 2-AG enhances excitatory glutamatergic synaptic transmission and induces neurotoxicity (Q48150926) (← links)
- [The endogenous cannabinoid system. Therapeutic implications for neurologic and psychiatric disorders]. (Q51993486) (← links)
- Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System. (Q55252194) (← links)
- TrpV1 receptor activation rescues neuronal function and network gamma oscillations from Aβ-induced impairment in mouse hippocampus in vitro (Q59809972) (← links)
- G-Protein-Coupled Receptors in CNS: A Potential Therapeutic Target for Intervention in Neurodegenerative Disorders and Associated Cognitive Deficits (Q89895162) (← links)
- Pharmacology of Medical Cannabis (Q92097863) (← links)